Twist Bioscience Corporation revenue for the last year amounted to 312.97 M USD, the most of which — 169.13 M USD — came from its highest performing source at the moment, Next Generation Sequencing Tools, the year earlier bringing 123.71 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Twist Bioscience Corporation 187.78 M USD, and the year before that — 147.07 M USD.